Genmab — Juli 2022

E_L

Positive opinion granted! There is your good news for the friday

Helge_LarsenPI-redaktør

Thanks E L .

E_L

The bad news is the new name, Tecvayli, ffs who makes these up

E_L

https://www.ema.europa.eu/en/medicines/human/summaries-opinion/tecvayli

Stroka

Ingen reaktion på aktiekursen.

Sukkeralf

E L regarding the ODD withdrawned it could be due to the marked size being bigger than expected.

deleted-user

Thx E L you never disappoint likewise Genmab

E_L

Thx. OK, thx, I was thinking in the same direction Sukkeralf. I am even thinking, IF they would broaden the indication outside of myeloma at some point, and that way reach more patients in total, if they would then loose orphan for myeloma anyway

E_L

But anyway, who cares, product #6 on it's way

Sukkeralf

Yes indeed fantastic and admirable

bibob

Ikke helt med Genmab.

JKY_VH

Jep, Genmab fortsat i grønt

Doublo

God morgen Ja og udover den dejlige stigning på Genmab har der endelig været lidt positiv bevægelse i A.P. Møller som jeg desværre/heldigvis? har en hulens masse af!!

bibob

Historisk Vinge( gaard) sus.

JKY_VH

Ja, det var flot bibob;-)

E_L

the Japanese Epcoritamab trial starts recruiting again, with a few additional arms added https://www.clinicaltrials.gov/ct2/history/NCT04542824?A=5&B=6&C=merged#StudyPageTop

bongobob

Thanks EL. Apparently Genmab has 21 investigational sites in Japan. Is that with staff or just agreements with clinics

E_L

no, they are all hospitals; you can see that in the earlier version they mentioned the names of the hospitals. I don't know why they changed it to read like this , but have seen it in more trials with other companies also

ProinvestorNEWS

Akter/middag: Bavarian rykker på godkendelse - banker kommer lidt igen https://www.proinvestor.com/investornyt/854869/akter-middag-bavarian-rykker-pa-godkendelse-banker-kommer-lidt-igen

Bulder

Ofatumumab forbedrer RMS-patienters kognition https://mstidsskrift.dk/37-sygdom/767-ofatumumab-forbedrer-rms-patienters-kognition.html